NEW YORK (360Dx) – Bill Gates and Alzheimer's Drug Discovery Foundation Leonard Lauder today announced a new initiative to develop new biomarkers for the early detection of Alzheimer's disease and related dementias.

Gates, Lauder, and others have committed more than $30 million to the initiative called Diagnostics Accelerator. Other philanthropists who are providing funding include the Dolby family and the Charles and Helen Schwab Foundation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.